FDA pharmacologic class
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
3 medicines are in FDA's class of human immunodeficiency virus integrase strand transfer inhibitors: raltegravir (Isentress), dolutegravir (Tivicay) and cabotegravir (Apretude); 5 combination products also contain one. 1 of the 8 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is isentress 400 mg tablet at $34.54 per tablet (NADAC).
Which medicines are human immunodeficiency virus integrase strand transfer inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Raltegravir | Isentress | 1 labeler | $34.54 per tablet 400 mg tablet | No | No current entry | 0 |
| Dolutegravir | Tivicay | none listed | $77.64 per tablet 50 mg tablet | No | No current entry | 3 |
| Cabotegravir | Apretude, Vocabria | none listed | n/a | Yes | No current entry | 0 |
| Abacavir and dolutegravir and lamivudine | Triumeq | none listed | $130.01 per tablet 600-50-300 mg tablet | Yes | No current entry | 1 |
| Cobicistat, elvitegravir, emtricitabine and tenofovir alafenamide | Genvoya | none listed | $143.35 per tablet Genvoya tablet | Yes | No current entry | 0 |
| Cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil | Stribild | none listed | $150.14 per tablet Stribild tablet | Yes | No current entry | 0 |
| Dolutegravir and lamivudine | Dovato | none listed | $105.22 per tablet 50-300 mg tablet | Yes | No current entry | 0 |
| Dolutegravir and rilpivirine | Juluca | none listed | $121.87 per tablet 50-25 mg tablet | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price